Hald, J. D. et al. (2026) Teriparatide plus zoledronic acid for osteogenesis imperfecta: a randomized clinical trial. Journal of the American Medical Association, 336(2), pp. 116-124. (doi: 10.1001/jama.2026.6889) Full text not currently available from Enlighten. Abstract IMPORTANCE: Osteogenesis imperfecta causes multiple fractures throughout life, causing substantial morbidity.
Jannie Dahl
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jannie
Contact Jannie, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack